COPENHAGEN, DENMARK – Hangzhou Singclean Medical Products Co., Ltd. made a strong impression at the 45th ESCRS Congress (European Society of Cataract and Refractive Surgeons), held September 12–16, 2025, at the Bella Center in Copenhagen. Recognized globally for its high professional standards and influence in ophthalmology, the congress gathered leading industry manufacturers, surgeons, and specialists from around the world.
At Booth C4.032, Singclean showcased its flagship Singclean® Viscoelastic Solution for Ophthalmic Surgery, attracting significant interest from attending surgeons and industry partners. The product, based on medical-grade sodium hyaluronate gel, is engineered to:
Create and maintain surgical space with reliability,
Deliver excellent cohesion and viscoelasticity,
Provide smooth, easy injection through ophthalmic needles.
These properties ensure enhanced operational control, safety, and efficiency, helping surgeons minimize complications such as tip blockage or injection resistance.
Singclean’s participation at ESCRS 2025 highlights the company’s commitment to innovation, quality, and patient safety in the global ophthalmic device market. Attendees had the opportunity to interact with the Singclean team and gain first-hand insight into the product’s applications and benefits.
For more information, visit www.singclean.net
or contact marketing@singclean.net
About Singclean Medical
Singclean Medical specializes in the development and production of high-quality medical devices, including ophthalmic surgical products. Focusing on innovation and user safety, Singclean continues to expand its global presence and strengthen its reputation in the healthcare industry.
Media Contact:
Marketing Department
Hangzhou Singclean Medical Products Co., Ltd.
Email: marketing@singclean.net
Website: www.singclean.net
-
singclean | 2025-09-17
Singderm Filler Achieves 92.7% Efficacy at 12 Months in Global Clinical Trial, Validated by Landmark Thailand MasterclassBangkok, Thailand – Singderm, a globally certified dermal filler brand, has demonstrated unprecedented clinical performance in its Thailand Masterclass led by renowned physician Dr. Worawat Nolah. Three top KOLs (Hack Anantaya, Chalidaorn PinNy, Thantaya Thuranuch) received multi-zone injections with zero complications, reinforcing Singderm’s 92.7% 12-month efficacy rate from a 100-subject clinical trial. -
singclean | 2025-09-17
Singclean to Showcase Innovative Medical Solutions at Key International Exhibitions in Bangkok and Copenhagen -
singclean | 2025-09-17
Singclean Medical Shines at WHX Kuala Lumpur 2025, IVD Solutions Garner Strong Attention Across ASEANKuala Lumpur, Malaysia | July 18, 2025 — From July 16 to 18, WHX Kuala Lumpur 2025, one of ASEAN’s most influential exhibitions for medical devices and laboratory equipment, took place in the Malaysian capital. The event gathered global healthcare technology leaders, and Singclean Medical, a leading Chinese in-vitro diagnostics (IVD) company, made a strong impression with its innovative and reliable total IVD solutions. Backed by solid product performance and technological excellence, Singclean attracted wide interest and recognition from professional attendees.
